Chemed (NYSE:CHE) Price Target Raised to $667.00 at Royal Bank of Canada
Chemed (NYSE:CHE – Free Report) had its price target hoisted by Royal Bank of Canada from $633.00 to $667.00 in a research report released on Friday,Benzinga reports. They currently have an outperform rating on the stock. Separately, StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th. […]
Chemed (NYSE:CHE – Free Report) had its price target hoisted by Royal Bank of Canada from $633.00 to $667.00 in a research report released on Friday,Benzinga reports. They currently have an outperform rating on the stock. Separately, StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th. […]
